Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review

[1]  T. Tabuchi,et al.  Coronavirus Disease , 2021, Encyclopedia of the UN Sustainable Development Goals.

[2]  I. Appollonio,et al.  Guillain-Barré syndrome related to COVID-19 infection , 2020, Neurology: Neuroimmunology & Neuroinflammation.

[3]  Thomas J Oxley,et al.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young , 2020, The New England journal of medicine.

[4]  Vasuki H. Dandu,et al.  COVID-19 presenting as stroke , 2020, Brain, Behavior, and Immunity.

[5]  Samir Abu-Rumeileh,et al.  Guillain-Barré syndrome following COVID-19: new infection, old complication? , 2020, Journal of Neurology.

[6]  H. El Otmani,et al.  Covid-19 and Guillain-Barré syndrome: More than a coincidence! , 2020, Revue Neurologique.

[7]  M. Balaan,et al.  Guillain-Barré Syndrome associated with SARS-CoV-2 infection , 2020, IDCases.

[8]  G. Grasselli,et al.  Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis , 2020, Journal of Thrombosis and Haemostasis.

[9]  F. Baldanti,et al.  Guillain–Barré Syndrome Associated with SARS-CoV-2 , 2020, The New England journal of medicine.

[10]  B. Pozzetto,et al.  COVID-19 may induce Guillain–Barré syndrome , 2020, Revue Neurologique.

[11]  N. Karimi,et al.  Guillain Barre syndrome associated with COVID-19 infection: A case report , 2020, Journal of Clinical Neuroscience.

[12]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[13]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[14]  Dingding Shen,et al.  Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? , 2020, The Lancet Neurology.

[15]  Jiagao Lv,et al.  Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection , 2020, Journal of the American Heart Association.

[16]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[17]  D. Cucinotta,et al.  WHO Declares COVID-19 a Pandemic , 2020, Acta bio-medica : Atenei Parmensis.

[18]  Usman Ali,et al.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms , 2020, ACS chemical neuroscience.

[19]  Rui Ji,et al.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[20]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[21]  A. Walls,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[22]  Tsutomu Hashikawa,et al.  The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients , 2020, Journal of medical virology.

[23]  王华英,et al.  Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series , 2020, BMJ.

[24]  H. Rothan,et al.  The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak , 2020, Journal of Autoimmunity.

[25]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[26]  J. Albert,et al.  Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child , 2020, Infectious diseases.

[27]  T. Velavan,et al.  The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.

[28]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[29]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[30]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[31]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[32]  Baoying Huang,et al.  Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice , 2019, Antiviral Research.

[33]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[34]  J. Rini,et al.  Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43 , 2018, Journal of Virology.

[35]  J. Gorodkin,et al.  TISSUES 2.0: an integrative web resource on mammalian tissue expression , 2018, Database J. Biol. Databases Curation.

[36]  A. Hajeer,et al.  Histopathology of Middle East respiratory syndrome coronovirus (MERS‐CoV) infection – clinicopathological and ultrastructural study , 2017, Histopathology.

[37]  J. Heo,et al.  Neurological Complications during Treatment of Middle East Respiratory Syndrome , 2017, Journal of clinical neurology.

[38]  L. Duffy,et al.  Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments , 2016, ImmunoTargets and therapy.

[39]  T. Jacques,et al.  Human Coronavirus OC43 Associated with Fatal Encephalitis. , 2016, The New England journal of medicine.

[40]  H. Algahtani,et al.  Neurological Complications of Middle East Respiratory Syndrome Coronavirus: A Report of Two Cases and Review of the Literature , 2016, Case reports in neurological medicine.

[41]  David K Meyerholz,et al.  Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4 , 2015, The Journal of infectious diseases.

[42]  A. Haydar,et al.  A rare cause of acute flaccid paralysis: Human coronaviruses , 2015, Journal of pediatric neurosciences.

[43]  S. Perlman,et al.  Coronaviruses: An Overview of Their Replication and Pathogenesis , 2015, Methods in molecular biology.

[44]  A. Hajeer,et al.  Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) , 2015, Infection.

[45]  J. Libbey,et al.  Axonal pathology and demyelination in viral models of multiple sclerosis. , 2014, Discovery medicine.

[46]  B. Stainsby,et al.  Neuromusculoskeletal disorders following SARS: a case series. , 2011, The Journal of the Canadian Chiropractic Association.

[47]  R. Ransohoff,et al.  Memory CD4+ T-Cell-Mediated Protection from Lethal Coronavirus Encephalomyelitis , 2008, Journal of Virology.

[48]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[49]  M. Desforges,et al.  Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients , 2007, Clinical Immunology.

[50]  F. Rovida,et al.  Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients , 2007, Journal of Clinical Virology.

[51]  E. Lazartigues,et al.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[52]  David K. Meyerholz,et al.  Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus , 2006, Journal of Virology.

[53]  G. Almazan,et al.  Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice , 2006, Virology.

[54]  N. Zhong,et al.  Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  L. Tsai,et al.  Neurological manifestations in severe acute respiratory syndrome. , 2005, Acta neurologica Taiwanica.

[56]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[57]  L. Tsai,et al.  Neuromuscular disorders in severe acute respiratory syndrome. , 2004, Archives of neurology.

[58]  P. Tan,et al.  Large artery ischaemic stroke in severe acute respiratory syndrome (SARS) , 2004, Journal of Neurology.

[59]  Qingling Zhang,et al.  Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.

[60]  K. Yuen,et al.  Possible Central Nervous System Infection by SARS Coronavirus , 2004, Emerging infectious diseases.

[61]  H. Faden,et al.  Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. , 2004, Pediatrics.

[62]  H. Wege.  Immunopathological aspects of coronavirus infections , 2004, Springer Seminars in Immunopathology.

[63]  Arul Earnest,et al.  Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. , 2003, JAMA.

[64]  J. Newcombe,et al.  Neuroinvasion by Human Respiratory Coronaviruses , 2000, Journal of Virology.

[65]  Gregory F. Wu,et al.  Macrophage Infiltration, but Not Apoptosis, Is Correlated with Immune-Mediated Demyelination following Murine Infection with a Neurotropic Coronavirus , 1999, Journal of Virology.

[66]  F. Chagnon,et al.  Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E , 1999, Journal of Virology.

[67]  P. Talbot,et al.  Involvement of Aminopeptidase N (CD13) in Infection of Human Neural Cells by Human Coronavirus 229E , 1998, Journal of Virology.

[68]  D. Grzybicki,et al.  Activation of Astrocytes in the Spinal Cord of Mice Chronically Infected with a Neurotropic Coronavirus , 1995, Virology.

[69]  J. Fleming,et al.  Demyelination induced by murine coronavirus JHM infection of congenitally immunodeficient mice. , 1995, Advances in experimental medicine and biology.

[70]  P. Talbot,et al.  Human coronavirus gene expression in the brains of multiple sclerosis patients , 1992, Virology.

[71]  R. Murray,et al.  Detection of coronavirus RNA and antigen in multiple sclerosis brain , 1992, Annals of neurology.